Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

1 INTRODUCTION 47 1.1 STUDY OBJECTIVES 47 1.2 MARKET DEFINITION 47 1.3 STUDY SCOPE 47 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 48 1.3.2 INCLUSIONS & EXCLUSIONS 49 1.3.3 YEARS CONSIDERED 49 1.4 MARKET STAKEHOLDERS 50 1.5 LIMITATIONS 50 1.6 SUMMARY OF CHANGES 50 2 RESEARCH METHODOLOGY 52 2.1 RESEARCH APPROACH 52 2.2 RESEARCH METHODOLOGY DESIGN 52 2.2.1 SECONDARY RESEARCH 53 2.2.1.1 Key data from secondary sources 54 2.2.2 PRIMARY DATA 54 2.2.2.1 Key data from primary sources 55 2.2.2.2 Key industry insights 56 2.3 MARKET SIZE ESTIMATION 58 2.3.1 BOTTOM-UP APPROACH 64 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 65 2.5 MARKET SHARE ESTIMATION 66 2.6 RESEARCH ASSUMPTIONS 66 2.7 RISK ASSESSMENT 67 2.8 RESEARCH LIMITATIONS 67 2.8.1 METHODOLOGY-RELATED LIMITATIONS 67 2.8.2 SCOPE-RELATED LIMITATIONS 67 3 EXECUTIVE SUMMARY 68 4 PREMIUM INSIGHTS 74 4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW 74 4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024) 75 4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX 76 4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 76 4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 77 5 MARKET OVERVIEW 78 5.1 MARKET DYNAMICS 78 5.1.1 DRIVERS 79 5.1.1.1 Growth in companion animal population 79 5.1.1.2 Increasing demand for animal-derived food products 81 5.1.1.3 Growing concerns about infectious zoonotic diseases 81 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure 83 5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets 85 5.1.1.6 Growing focus on disease control & prevention measures 86 5.1.2 RESTRAINTS 86 5.1.2.1 Rising pet care costs 86 5.1.2.2 High cost of veterinary diagnostic tests 87 5.1.3 OPPORTUNITIES 87 5.1.3.1 Growth potential of emerging economies 87 5.1.3.2 Integration of AI & ML 88 5.1.4 CHALLENGES 88 5.1.4.1 Low animal healthcare awareness in emerging countries 88 5.1.4.2 Shortage of veterinary practitioners in emerging economies 88 5.2 INDUSTRY TRENDS 89 5.2.1 ADOPTION OF MULTIPLE TEST PANELS 89 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 90 5.2.3 GROWING SCALE OF VETERINARY BUSINESSES 90 5.3 TECHNOLOGY ANALYSIS 91 5.3.1 KEY TECHNOLOGIES 91 5.3.1.1 Portable instruments for POC diagnostic services 91 5.3.1.2 Biosensor-based diagnostic systems 91 5.3.2 ADJACENT TECHNOLOGIES 92 5.3.2.1 Wearable biosensors & remote monitoring devices 92 5.3.2.2 Rapid & sensitive veterinary diagnostic kits 92 5.3.2.3 Breath & saliva-based diagnostic tools 93 5.3.2.4 Microfluidics & Lab-on-a-chip devices 93 5.3.3 COMPLEMENTARY TECHNOLOGIES 94 5.3.3.1 AI-driven diagnostic platforms 94 5.3.3.2 Next-generation sequencing (NGS) 94 5.4 PORTER’S FIVE FORCES ANALYSIS 95 5.4.1 THREAT OF NEW ENTRANTS 96 5.4.2 THREAT OF SUBSTITUTES 96 5.4.3 BARGAINING POWER OF SUPPLIERS 97 5.4.4 BARGAINING POWER OF BUYERS 97 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 97 5.5 REGULATORY ANALYSIS 97 5.5.1 REGULATORY LANDSCAPE 97 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 5.5.2.1 North America 98 5.5.2.2 Europe 99 5.5.2.3 Rest of the World 99 5.6 PATENT ANALYSIS 100 5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS 100 5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS 102 5.7 TRADE ANALYSIS 104 5.7.1 TRADE DATA FOR HS CODE 9018 104 5.7.1.1 Import data for HS Code 9018 104 5.7.1.2 Export data for HS Code 9018 105 5.8 PRICING ANALYSIS 105 5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 106 5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022–2024 107 5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024 108 5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022–2024 108 5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022–2024 109 5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022–2024 109 5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022–2024 110 5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022–2024 110 5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022–2024 111 5.9 REIMBURSEMENT ANALYSIS 111 5.10 KEY CONFERENCES & EVENTS, 2025–2026 112 5.11 KEY STAKEHOLDERS & BUYING CRITERIA 113 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 113 5.11.2 BUYING CRITERIA 114 5.12 END-USER PERSPECTIVE & UNMET NEEDS 115 5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 116 5.13.1 INTRODUCTION 116 5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM 116 5.13.3 AI USE CASES 117 5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS 117 5.14 ECOSYSTEM ANALYSIS 118 5.15 VALUE CHAIN ANALYSIS 120 5.16 SUPPLY CHAIN ANALYSIS 121 5.17 ADJACENT MARKET ANALYSIS 122 5.18 INVESTMENT & FUNDING SCENARIO 123 5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 124 5.19.1 INTRODUCTION 124 5.19.2 KEY TARIFF RATES 125 5.19.3 PRICE IMPACT ANALYSIS 126 5.19.4 IMPACT ON COUNTRY/REGION 127 5.19.5 IMPACT ON END-USE INDUSTRIES 129 6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT 130 6.1 INTRODUCTION 131 6.2 CONSUMABLES 133 6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH 133 6.3 INSTRUMENTS 135 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH 135 7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY 138 7.1 INTRODUCTION 139 7.2 IMMUNODIAGNOSTICS 139 7.2.1 LATERAL FLOW ASSAYS 142 7.2.1.1 Lateral flow rapid tests 146 7.2.1.1.1 Ability to provide real-time insights to drive market 146 7.2.1.2 Lateral flow strip readers 148 7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption 148 7.2.2 ELISA TESTS 150 7.2.2.1 Cost-effectiveness and ease of use to drive market 150 7.2.3 IMMUNOASSAY ANALYZERS 152 7.2.3.1 High sensitivity & specificity for biomarker detection to drive market 152 7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES 155 7.3 MOLECULAR DIAGNOSTICS 157 7.3.1 PCR TESTS 160 7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth 160 7.3.2 NUCLEIC ACID SEQUENCING 163 7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market 163 7.3.3 MICROARRAYS 165 7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market 165 7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES 167 7.4 OTHER TECHNOLOGIES 169 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE 171 8.1 INTRODUCTION 172 8.2 COMPANION ANIMALS 172 8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE 175 8.2.1.1 Dogs 175 8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market 175 8.2.1.2 Cats 178 8.2.1.2.1 Growing pet cat population to support growth 178 8.2.1.3 Horses 180 8.2.1.3.1 Growing equine health awareness to drive market 180 8.2.1.4 Other companion animals 182 8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY 184 8.2.2.1 Immunodiagnostics 184 8.2.2.1.1 Lateral flow assays 188 8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth 188 8.2.2.1.2 ELISA tests 190 8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market 190 8.2.2.1.3 Immunoassay analyzers 192 8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers 192 8.2.2.1.4 Other immunodiagnostic technologies 194 8.2.2.2 Molecular diagnostics 195 8.2.2.2.1 PCR tests 198 8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption 198 8.2.2.2.2 Nucleic acid sequencing 200 8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth 200 8.2.2.2.3 Microarrays 202 8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays 202 8.2.2.2.4 Other molecular diagnostic technologies 203 8.2.2.3 Other technologies 205   8.3 LIVESTOCK 207 8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE 210 8.3.1.1 Cattle 210 8.3.1.1.1 Growing consumption of meat to support market growth 210 8.3.1.2 Pigs 213 8.3.1.2.1 Growing incidence of infectious diseases to drive market 213 8.3.1.3 Poultry 215 8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth 215 8.3.1.4 Other livestock 217 8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY 219 8.3.2.1 Immunodiagnostics 219 8.3.2.1.1 Lateral flow assays 223 8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand 223 8.3.2.1.2 ELISA tests 224 8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market 224 8.3.2.1.3 Immunoassay analyzers 227 8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market 227 8.3.2.1.4 Other immunodiagnostic technologies 229 8.3.2.2 Molecular diagnostics 231 8.3.2.2.1 PCR tests 233 8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth 233 8.3.2.2.2 Nucleic acid sequencing 236 8.3.2.2.2.1 Identification of pathogens to fuel market 236 8.3.2.2.3 Microarrays 238 8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth 238 8.3.2.2.4 Other molecular diagnostic technologies 239 8.3.2.3 Other technologies 241 9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER 243 9.1 INTRODUCTION 244 9.2 VETERINARY REFERENCE LABORATORIES 244 9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET 244 9.3 VETERINARY HOSPITALS & CLINICS 246 9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET 246 9.4 POINT-OF-CARE/IN-HOUSE TESTING 248 9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND 248   9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 250 9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH 250 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION 252 10.1 INTRODUCTION 253 10.2 NORTH AMERICA 254 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 255 10.2.2 US 262 10.2.2.1 High veterinary healthcare expenditure to drive market 262 10.2.3 CANADA 268 10.2.3.1 Growing pet adoption to drive market 268 10.3 EUROPE 274 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 275 10.3.2 GERMANY 281 10.3.2.1 Rising awareness of zoonotic diseases to fuel market 281 10.3.3 UK 287 10.3.3.1 Increasing pet ownership to drive market 287 10.3.4 FRANCE 293 10.3.4.1 Willingness of pet owners to spend on pet health to drive market 293 10.3.5 ITALY 299 10.3.5.1 Growing consumption of meat & dairy products to drive market 299 10.3.6 SPAIN 305 10.3.6.1 Growing demand for poultry products to fuel market 305 10.3.7 NETHERLANDS 311 10.3.7.1 Developments in veterinary diagnostic products to support market growth 311 10.3.8 REST OF EUROPE 317 10.4 ASIA PACIFIC 322 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 324 10.4.2 CHINA 331 10.4.2.1 Increasing incidence of zoonotic diseases to propel market 331 10.4.3 JAPAN 337 10.4.3.1 Increasing pet expenditure to support market growth 337 10.4.4 INDIA 343 10.4.4.1 Increasing demand for dairy products to drive market 343 10.4.5 AUSTRALIA 350 10.4.5.1 Rise in pet ownership to support market growth 350 10.4.6 SOUTH KOREA 356 10.4.6.1 Rising need for specialized veterinary services to drive market 356 10.4.7 NEW ZEALAND 362 10.4.7.1 Focus on pet insurance to aid market 362   10.4.8 VIETNAM 368 10.4.8.1 Growing focus on disease surveillance to drive market 368 10.4.9 REST OF ASIA PACIFIC 374 10.5 LATIN AMERICA 379 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 380 10.5.2 BRAZIL 385 10.5.2.1 Growth in livestock industry to boost demand 385 10.5.3 MEXICO 391 10.5.3.1 Increasing focus on poultry-associated products to support market growth 391 10.5.4 REST OF LATIN AMERICA 397 10.6 MIDDLE EAST & AFRICA 402 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 403 10.6.2 GCC COUNTRIES 409 10.6.2.1 Kingdom of Saudi Arabia (KSA) 415 10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand 415 10.6.2.2 United Arab Emirates (UAE) 420 10.6.2.2.1 Favorable government support for vet diagnostics to drive market 420 10.6.2.3 Rest of GCC Countries 426 10.6.3 REST OF MIDDLE EAST & AFRICA 431 11 COMPETITIVE LANDSCAPE 437 11.1 OVERVIEW 437 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 437 11.3 REVENUE ANALYSIS, 2020–2024 439 11.4 MARKET SHARE ANALYSIS, 2024 439 11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS 440 11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK 441 11.4.3 RANKING OF KEY MARKET PLAYERS 442 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 443 11.5.1 STARS 443 11.5.2 EMERGING LEADERS 444 11.5.3 PERVASIVE PLAYERS 444 11.5.4 PARTICIPANTS 444 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 445 11.5.5.1 Company footprint 445 11.5.5.2 Region footprint 446 11.5.5.3 Product footprint 447 11.5.5.4 Technology footprint 448 11.5.5.5 Animal type footprint 449   11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 450 11.6.1 PROGRESSIVE COMPANIES 450 11.6.2 RESPONSIVE COMPANIES 450 11.6.3 DYNAMIC COMPANIES 450 11.6.4 STARTING BLOCKS 450 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 452 11.6.5.1 Detailed list of key startups/SMEs 452 11.6.5.2 Competitive benchmarking of key startups 453 11.7 BRAND/PRODUCT COMPARISON 454 11.8 R&D EXPENDITURE OF KEY PLAYERS 455 11.9 COMPANY VALUATION & FINANCIAL METRICS 455 11.9.1 FINANCIAL METRICS 455 11.9.2 COMPANY VALUATION 456 11.10 COMPETITIVE SCENARIO 456 11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS 456 11.10.2 DEALS 457 11.10.3 EXPANSIONS 458 11.10.4 OTHER DEVELOPMENTS 458 12 COMPANY PROFILES 459 12.1 KEY PLAYERS 459 12.1.1 IDEXX LABORATORIES, INC. 459 12.1.1.1 Business overview 459 12.1.1.2 Products & services offered 460 12.1.1.3 Recent developments 464 12.1.1.3.1 Product/Service launches & enhancements 464 12.1.1.4 MnM view 465 12.1.1.4.1 Key strengths 465 12.1.1.4.2 Strategic choices 465 12.1.1.4.3 Weaknesses & competitive threats 466 12.1.2 ZOETIS SERVICES LLC 467 12.1.2.1 Business overview 467 12.1.2.2 Products & services offered 468 12.1.2.3 Recent developments 470 12.1.2.3.1 Product enhancements 470 12.1.2.3.2 Deals 470 12.1.2.3.3 Expansions 471 12.1.2.4 MnM view 471 12.1.2.4.1 Key strengths 471 12.1.2.4.2 Strategic choices 472 12.1.2.4.3 Weaknesses & competitive threats 472   12.1.3 THERMO FISHER SCIENTIFIC INC. 473 12.1.3.1 Business overview 473 12.1.3.2 Products & services offered 474 12.1.3.3 MnM view 480 12.1.3.3.1 Key strengths 480 12.1.3.3.2 Strategic choices 480 12.1.3.3.3 Weaknesses & competitive threats 480 12.1.4 VIRBAC 481 12.1.4.1 Business overview 481 12.1.4.2 Products & services offered 482 12.1.4.3 Recent developments 483 12.1.4.3.1 Deals 483 12.1.4.3.2 Expansions 483 12.1.4.4 MnM view 484 12.1.4.4.1 Key strengths 484 12.1.4.4.2 Strategic choices 484 12.1.4.4.3 Weaknesses & competitive threats 484 12.1.5 BIOMÉRIEUX 485 12.1.5.1 Business overview 485 12.1.5.2 Products & services offered 486 12.1.5.3 Recent developments 487 12.1.5.3.1 Product launches & approvals 487 12.1.5.4 MnM view 487 12.1.5.4.1 Key strengths 487 12.1.5.4.2 Strategic choices 487 12.1.5.4.3 Weaknesses & competitive threats 488 12.1.6 ANTECH DIAGNOSTICS, INC. 489 12.1.6.1 Business overview 489 12.1.6.2 Products & services offered 489 12.1.6.3 Recent developments 490 12.1.6.3.1 Product launches 490 12.1.6.3.2 Expansions 491 12.1.7 INNOVATIVE DIAGNOSTICS 492 12.1.7.1 Business overview 492 12.1.7.2 Products & services offered 492 12.1.8 NEOGEN CORPORATION 500 12.1.8.1 Business overview 500 12.1.8.2 Products & services offered 501 12.1.8.2.1 Other developments 502 12.1.9 INDICAL BIOSCIENCE GMBH 503 12.1.9.1 Business overview 503 12.1.9.2 Products & services offered 503 12.1.9.3 Recent developments 505 12.1.9.3.1 Product enhancements 505 12.1.10 AGROLABO S.P.A. 506 12.1.10.1 Business overview 506 12.1.10.2 Products & services offered 506 12.1.11 BIONOTE 510 12.1.11.1 Business overview 510 12.1.11.2 Products & services offered 510 12.1.11.3 Recent developments 512 12.1.11.4 Product launches 512 12.1.11.4.1 Deals 513 12.1.12 BIOGAL 514 12.1.12.1 Business overview 514 12.1.12.2 Products & services offered 514 12.1.13 BIOCHEK 516 12.1.13.1 Business overview 516 12.1.13.2 Products & services offered 516 12.1.13.3 Recent developments 519 12.1.13.3.1 Product launches 519 12.1.13.3.2 Deals 519 12.1.14 MEGACOR DIAGNOSTIK GMBH 520 12.1.14.1 Business overview 520 12.1.14.2 Products & services offered 520 12.1.14.3 Recent developments 526 12.1.14.3.1 Product launches & enhancements 526 12.1.15 BIO-RAD LABORATORIES, INC. 527 12.1.15.1 Business overview 527 12.1.15.2 Products & services offered 528 12.2 OTHER PLAYERS 530 12.2.1 FASSISI, GMBH 530 12.2.2 BIOTANGENTS LIMITED 531 12.2.3 SKYER, INC. 531 12.2.4 BIOPANDA REAGENTS LTD. 532 12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC. 533 12.2.6 GOLD STANDARD DIAGNOSTICS 534 12.2.7 BIO-X DIAGNOSTICS S.A. 535 12.2.8 DEMEDITEC DIAGNOSTICS GMBH 536 12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 537 12.2.10 BIOSTONE ANIMAL HEALTH 538   13 APPENDIX 539 13.1 DISCUSSION GUIDE 539 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 544 13.3 RELATED REPORTS 546 13.4 AUTHOR DETAILS 547

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 50 TABLE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS 66 TABLE 3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS 67 TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS) 79 TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023) 82 TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023 84 TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION) 85 TABLE 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 95 TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 TABLE 12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS 103 TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSAND) 104 TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSAND) 105 TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 106 TABLE 16 AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022–2024 108 TABLE 17 AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022–2024 109 TABLE 18 AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022–2024 109 TABLE 19 AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022–2024 110 TABLE 20 AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022–2024 110 TABLE 21 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022–2024 111 TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 112 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%) 113 TABLE 24 KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 115 TABLE 25 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS 118 TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 119 TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 125 TABLE 28 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 125 TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 127 TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 127 TABLE 31 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 128 TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 129 TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 131 TABLE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 35 KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES 134 TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 37 KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS 136 TABLE 38 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 39 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 139 TABLE 40 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES 140 TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 43 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS 143 TABLE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023–2030 (THOUSAND UNITS) 143 TABLE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS 146 TABLE 48 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 49 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS 148 TABLE 50 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS 150 TABLE 52 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023–2030 (THOUSAND UNITS) 151 TABLE 53 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 54 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS 153 TABLE 55 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (THOUSAND UNITS) 153 TABLE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES 155 TABLE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 59 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS 157 TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 61 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 62 KEY PLAYERS PROVIDING PCR TESTS 160 TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023–2030 (THOUSAND UNITS) 161 TABLE 64 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 65 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING 163 TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023–2030 (THOUSAND UNITS) 163 TABLE 67 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 68 KEY PLAYERS PROVIDING MICROARRAYS 165 TABLE 69 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (THOUSAND UNITS) 165 TABLE 70 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 71 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES 167 TABLE 72 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 73 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES 169 TABLE 74 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 75 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 172 TABLE 76 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS 173 TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 79 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS 176 TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 81 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS 178 TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 83 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES 180 TABLE 84 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 85 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS 182 TABLE 86 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 87 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 184 TABLE 88 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS 185 TABLE 89 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 90 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 91 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS 188 TABLE 92 COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 93 KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS 190 TABLE 94 COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 95 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS 192 TABLE 96 COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 97 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS 194 TABLE 98 COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 99 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS 196 TABLE 100 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 101 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 102 KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS 198 TABLE 103 COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 104 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS 200 TABLE 105 COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 106 KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS 202 TABLE 107 COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 108 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS 204 TABLE 109 COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 110 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS 205 TABLE 111 COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 112 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK 208 TABLE 113 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 114 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 115 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE 211 TABLE 116 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 117 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS 213 TABLE 118 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 119 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY 215 TABLE 120 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 121 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS 217 TABLE 122 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 123 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 219 TABLE 124 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK 220 TABLE 125 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 126 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 127 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK 223 TABLE 128 LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 129 KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK 225 TABLE 130 LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 131 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK 227 TABLE 132 LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 133 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK 229 TABLE 134 LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 135 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK 231 TABLE 136 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 137 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 138 KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK 234 TABLE 139 LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 140 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK 236 TABLE 141 LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 142 KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK 238 TABLE 143 LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 144 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK 240 TABLE 145 LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 146 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK 241 TABLE 147 LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 148 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 244 TABLE 149 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 150 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD) 246 TABLE 151 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 152 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 153 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 154 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 254 TABLE 155 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 156 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 257 TABLE 157 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 257 TABLE 158 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 159 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 160 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 161 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 258 TABLE 162 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 163 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 259 TABLE 164 NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 165 NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 166 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 167 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 260 TABLE 168 NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 169 NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 170 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 171 US: KEY MACROINDICATORS 263 TABLE 172 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 263 TABLE 173 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 263 TABLE 174 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 175 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 176 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 177 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 265 TABLE 178 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 179 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 265 TABLE 180 US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 181 US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 182 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 183 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 267 TABLE 184 US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 185 US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 186 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 268 TABLE 187 CANADA: KEY MACROINDICATORS 269 TABLE 188 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 269 TABLE 189 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 269 TABLE 190 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 191 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 192 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 193 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 271 TABLE 194 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 195 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 271 TABLE 196 CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 197 CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 198 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 199 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 273 TABLE 200 CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 201 CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 202 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 274 TABLE 203 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 204 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 276 TABLE 205 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 276 TABLE 206 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 207 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 208 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 209 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 277 TABLE 210 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 211 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 278 TABLE 212 EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 213 EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 214 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 215 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 279 TABLE 216 EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 217 EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 218 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 219 GERMANY: KEY MACROINDICATORS 282 TABLE 220 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 282 TABLE 221 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 282 TABLE 222 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 223 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 224 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 225 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 284 TABLE 226 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 227 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 284 TABLE 228 GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 229 GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 230 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 231 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 286 TABLE 232 GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 233 GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 234 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 235 UK: KEY MACROINDICATORS 288 TABLE 236 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 288 TABLE 237 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 289 TABLE 238 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 239 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 240 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 241 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 290 TABLE 242 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 243 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 291 TABLE 244 UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 245 UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 246 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 247 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 292 TABLE 248 UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 249 UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 250 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 293 TABLE 251 FRANCE: KEY MACROINDICATORS 294 TABLE 252 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 294 TABLE 253 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 294 TABLE 254 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 255 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 256 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 257 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 296 TABLE 258 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 259 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 296 TABLE 260 FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 261 FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 262 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 263 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 298 TABLE 264 FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 265 FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 266 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 267 ITALY: KEY MACROINDICATORS 300 TABLE 268 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 300 TABLE 269 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 300 TABLE 270 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 271 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 272 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 273 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 302 TABLE 274 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 275 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 302 TABLE 276 ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 277 ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 278 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 279 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 304 TABLE 280 ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 281 ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 282 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 305 TABLE 283 SPAIN: KEY MACROINDICATORS 306 TABLE 284 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 306 TABLE 285 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 306 TABLE 286 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 287 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 288 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 289 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 308 TABLE 290 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 291 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 308 TABLE 292 SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 293 SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 294 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 295 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 310 TABLE 296 SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 297 SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 298 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 311 TABLE 299 NETHERLANDS: KEY MACROINDICATORS 312 TABLE 300 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 312 TABLE 301 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 312 TABLE 302 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 303 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 304 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 305 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 314 TABLE 306 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 307 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 314 TABLE 308 NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 309 NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 310 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 311 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 316 TABLE 312 NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 313 NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 314 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 317 TABLE 315 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 317 TABLE 316 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 318 TABLE 317 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 318 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 319 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 320 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 319 TABLE 321 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 322 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 320 TABLE 323 REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 324 REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 325 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 326 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 321 TABLE 327 REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 328 REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 329 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 330 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 326 TABLE 331 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 326 TABLE 332 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 326 TABLE 333 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 334 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 335 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 336 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 328 TABLE 337 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 338 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 328 TABLE 339 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 340 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 341 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 342 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 330 TABLE 343 ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 344 ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 345 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 331 TABLE 346 CHINA: KEY MACROINDICATORS 332 TABLE 347 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 332 TABLE 348 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 332 TABLE 349 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 350 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 351 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 352 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 334 TABLE 353 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 354 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 334 TABLE 355 CHINA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 356 CHINA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 357 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 358 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 336 TABLE 359 CHINA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 360 CHINA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 361 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 362 JAPAN: KEY MACROINDICATORS 338 TABLE 363 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 338 TABLE 364 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 339 TABLE 365 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 366 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 367 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 368 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 340 TABLE 369 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 370 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 341 TABLE 371 JAPAN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 372 JAPAN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 373 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 374 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 342 TABLE 375 JAPAN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 376 JAPAN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 377 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 343 TABLE 378 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 345 TABLE 379 INDIA: KEY MACROINDICATORS 345 TABLE 380 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 345 TABLE 381 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 346 TABLE 382 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 383 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 384 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 385 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 347 TABLE 386 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 387 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 348 TABLE 388 INDIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 389 INDIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 390 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 391 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 349 TABLE 392 INDIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 393 INDIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 394 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 395 AUSTRALIA: KEY MACROINDICATORS 351 TABLE 396 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 351 TABLE 397 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 351 TABLE 398 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 399 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 400 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 401 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 353 TABLE 402 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 403 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 353 TABLE 404 AUSTRALIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 405 AUSTRALIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 406 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 407 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 355 TABLE 408 AUSTRALIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 409 AUSTRALIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 410 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 356 TABLE 411 SOUTH KOREA: KEY MACROINDICATORS 356 TABLE 412 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 357 TABLE 413 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 357 TABLE 414 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 415 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 416 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 417 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 358 TABLE 418 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 419 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 359 TABLE 420 SOUTH KOREA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 421 SOUTH KOREA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 422 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 423 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 360 TABLE 424 SOUTH KOREA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 425 SOUTH KOREA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 426 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 362 TABLE 427 NEW ZEALAND: KEY MACROINDICATORS 362 TABLE 428 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 363 TABLE 429 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 363 TABLE 430 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 431 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 432 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 433 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 364 TABLE 434 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 435 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 365 TABLE 436 NEW ZEALAND: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 437 NEW ZEALAND: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 438 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 439 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 366 TABLE 440 NEW ZEALAND: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 441 NEW ZEALAND: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 442 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 368 TABLE 443 VIETNAM: KEY MACROINDICATORS 368 TABLE 444 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 369 TABLE 445 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 369 TABLE 446 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 447 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 448 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 449 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 370 TABLE 450 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 451 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 371 TABLE 452 VIETNAM: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 453 VIETNAM: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 454 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 455 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 372 TABLE 456 VIETNAM: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 457 VIETNAM: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 458 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 373 TABLE 459 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 374 TABLE 460 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 374 TABLE 461 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 462 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 463 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 464 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 376 TABLE 465 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 466 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 376 TABLE 467 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 468 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 469 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 470 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 378 TABLE 471 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 472 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 473 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 379 TABLE 474 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 380 TABLE 475 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 380 TABLE 476 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 381 TABLE 477 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 478 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 479 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 480 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 382 TABLE 481 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 482 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 383 TABLE 483 LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 484 LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 485 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 486 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 384 TABLE 487 LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 488 LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 489 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 385 TABLE 490 BRAZIL: KEY MACROINDICATORS 386 TABLE 491 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 386 TABLE 492 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 386 TABLE 493 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 494 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 495 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 496 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 388 TABLE 497 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 498 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 388 TABLE 499 BRAZIL: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 500 BRAZIL: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 501 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 502 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 390 TABLE 503 BRAZIL: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 504 BRAZIL: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 505 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 391 TABLE 506 MEXICO: KEY MACROINDICATORS 391 TABLE 507 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 392 TABLE 508 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 392 TABLE 509 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 510 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 511 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 512 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 393 TABLE 513 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 514 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 394 TABLE 515 MEXICO: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 516 MEXICO: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 517 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 518 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 395 TABLE 519 MEXICO: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 520 MEXICO: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 521 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 397 TABLE 522 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 397 TABLE 523 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 398 TABLE 524 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 525 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 526 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 527 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 399 TABLE 528 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 529 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 400 TABLE 530 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 531 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 532 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 533 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 401 TABLE 534 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 535 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 536 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 402 TABLE 537 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 404 TABLE 538 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 404 TABLE 539 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 404 TABLE 540 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 541 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 542 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 543 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 406 TABLE 544 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 545 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 406 TABLE 546 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 547 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 548 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 549 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 408 TABLE 550 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, B Y TYPE, 2023–2030 (USD MILLION) 408 TABLE 551 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 552 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 409 TABLE 553 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 409 TABLE 554 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 410 TABLE 555 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 410 TABLE 556 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 557 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 558 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 559 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 411 TABLE 560 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 561 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 412 TABLE 562 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 563 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 564 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 565 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 413 TABLE 566 GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 567 GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 568 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 414 TABLE 569 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 415 TABLE 570 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 415 TABLE 571 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 416 TABLE 572 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 573 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 574 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 575 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 417 TABLE 576 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 577 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 418 TABLE 578 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 579 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 580 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 581 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 419 TABLE 582 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 583 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 584 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 420 TABLE 585 UNITED ARAB EMIRATES: KEY MACROINDICATORS 421 TABLE 586 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 421 TABLE 587 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 421 TABLE 588 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 589 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 590 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 591 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 423 TABLE 592 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 593 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 423 TABLE 594 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 595 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 596 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 597 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 425 TABLE 598 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 599 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 600 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 426 TABLE 601 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 426 TABLE 602 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 427 TABLE 603 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 604 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 605 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 606 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 428 TABLE 607 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 608 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 429 TABLE 609 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 610 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 611 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 612 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 430 TABLE 613 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 614 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 431 TABLE 615 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 431 TABLE 616 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 432 TABLE 617 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 432 TABLE 618 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 619 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 620 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 621 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 433 TABLE 622 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 623 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION) 434 TABLE 624 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 625 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 626 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 627 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION) 435 TABLE 628 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 629 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 630 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 436 TABLE 631 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 437 TABLE 632 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS: DEGREE OF COMPETITION 440 TABLE 633 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK: DEGREE OF COMPETITION 441 TABLE 634 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGION FOOTPRINT 446 TABLE 635 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT FOOTPRINT 447 TABLE 636 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT 448 TABLE 637 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT 449 TABLE 638 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 452 TABLE 639 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS 453 TABLE 640 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 456 TABLE 641 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEALS, JANUARY 2022–MAY 2025 457 TABLE 642 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 458 TABLE 643 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 458 TABLE 644 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 459 TABLE 645 IDEXX LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 460 TABLE 646 IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 464 TABLE 647 ZOETIS SERVICES LLC: COMPANY OVERVIEW 467 TABLE 648 ZOETIS SERVICES LLC: PRODUCTS & SERVICES OFFERED 468 TABLE 649 ZOETIS SERVICES LLC: PRODUCT ENHANCEMENTS, JANUARY 2022–MAY 2025 470 TABLE 650 ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025 470 TABLE 651 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025 471 TABLE 652 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 473 TABLE 653 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 474 TABLE 654 VIRBAC: COMPANY OVERVIEW 481 TABLE 655 VIRBAC: PRODUCTS & SERVICES OFFERED 482 TABLE 656 VIRBAC: DEALS, JANUARY 2022–MAY 2025 483 TABLE 657 VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025 483 TABLE 658 BIOMÉRIEUX: COMPANY OVERVIEW 485 TABLE 659 BIOMÉRIEUX: PRODUCTS & SERVICES OFFERED 486 TABLE 660 BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 487 TABLE 661 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW 489 TABLE 662 ANTECH DIAGNOSTICS, INC.: PRODUCTS & SERVICES OFFERED 489 TABLE 663 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 490 TABLE 664 ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025 491 TABLE 665 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 492 TABLE 666 INNOVATIVE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED 492 TABLE 667 NEOGEN CORPORATION: COMPANY OVERVIEW 500 TABLE 668 NEOGEN CORPORATION: PRODUCTS & SERVICES OFFERED 501 TABLE 669 NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 502 TABLE 670 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 503 TABLE 671 INDICAL BIOSCIENCE GMBH: PRODUCTS & SERVICES OFFERED 503 TABLE 672 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022–MAY 2025 505 TABLE 673 AGROLABO S.P.A.: COMPANY OVERVIEW 506 TABLE 674 AGROLABO S.P.A.: PRODUCTS & SERVICES OFFERED 506 TABLE 675 BIONOTE: COMPANY OVERVIEW 510 TABLE 676 BIONOTE: PRODUCTS & SERVICES OFFERED 510 TABLE 677 BIONOTE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 512 TABLE 678 BIONOTE: DEALS, JANUARY 2022–MAY 2025 513 TABLE 679 BIOGAL: COMPANY OVERVIEW 514 TABLE 680 BIOGAL: PRODUCTS & SERVICES OFFERED 514 TABLE 681 BIOCHEK: COMPANY OVERVIEW 516 TABLE 682 BIOCHEK: PRODUCTS & SERVICES OFFERED 516 TABLE 683 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 519 TABLE 684 BIOCHEK: DEALS, JANUARY 2022–MAY 2025 519 TABLE 685 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW 520 TABLE 686 MEGACOR DIAGNOSTIK GMBH: PRODUCTS & SERVICES OFFERED 520 TABLE 687 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 526 TABLE 688 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 527 TABLE 689 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 528 TABLE 690 FASSISI, GMBH: COMPANY OVERVIEW 530 TABLE 691 BIOTANGENTS LIMITED: COMPANY OVERVIEW 531 TABLE 692 SKYER, INC.: COMPANY OVERVIEW 531 TABLE 693 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW 532 TABLE 694 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 533 TABLE 695 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 534 TABLE 696 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW 535 TABLE 697 DEMEDITEC DIAGNOSTICS GMBH: COMPANY OVERVIEW 536 TABLE 698 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW 537 TABLE 699 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW 538 FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE 48 FIGURE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN 52 FIGURE 3 PRIMARY SOURCES 54 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 56 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 57 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 57 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 58 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 59 FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024) 59 FIGURE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS 61 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025–2030) 62 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 63 FIGURE 13 TOP-DOWN APPROACH 63 FIGURE 14 BOTTOM-UP APPROACH 64 FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY 65 FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 68 FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 69 FIGURE 18 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION) 69 FIGURE 19 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION) 70 FIGURE 20 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 70 FIGURE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION) 71 FIGURE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 72 FIGURE 23 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 72 FIGURE 24 GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 73 FIGURE 25 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH 74 FIGURE 26 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024 75 FIGURE 27 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 76 FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 76 FIGURE 29 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 77 FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 78 FIGURE 31 EUROPE: PET POPULATION, 2021–2023 80 FIGURE 32 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD) 84 FIGURE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 95 FIGURE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025) 101 FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014–MAY 2025) 102 FIGURE 36 AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024 107 FIGURE 37 AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024 108 FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 113 FIGURE 39 KEY BUYING CRITERIA FOR TOP THREE END USERS 114 FIGURE 40 AI USE CASES 117 FIGURE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 119 FIGURE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 120 FIGURE 43 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 122 FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS 122 FIGURE 45 INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020–2024 123 FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 253 FIGURE 47 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030 255 FIGURE 48 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT 256 FIGURE 49 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 323 FIGURE 50 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 324 FIGURE 51 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT 325 FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020–2024) 439 FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024) 440 FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024) 441 FIGURE 55 RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024 442 FIGURE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 444 FIGURE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT 445 FIGURE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 451 FIGURE 59 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 454 FIGURE 60 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022–2024 455 FIGURE 61 EV/EBITDA OF KEY VENDORS 455 FIGURE 62 YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 456 FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 460 FIGURE 64 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024) 468 FIGURE 65 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 474 FIGURE 66 VIRBAC: COMPANY SNAPSHOT (2024) 482 FIGURE 67 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 486 FIGURE 68 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024) 501 FIGURE 69 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 528